In addition, ERBB3 participates in neutrophil survival and ERBB3 inhibitors play positive roles in accelerating inflammation resolution [29], which is a known predisposing factor for the development and progression of hypertension and overweight. This evidence concerns the gene ERBB3 and hypertensive disorder.